Metabolism and rna incorporation of cyclopentenyl cytosine in human colorectal cancer cells

Biochemical Pharmacology

Volumn 43, Issue 7, 1992, Pages 1587-1599

  Yee, Lorrin K ^a   Allegra, Carmen J ^a   Trepel, Jane B ^b   Grem, Jean L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Clinical Practice Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE; CYTIDINE DEAMINASE; CYTIDINE TRIPHOSPHATE; DEOXYCYTIDINE PHOSPHATE DEAMINASE; DEOXYCYTIDINE TRIPHOSPHATE; RADIOISOTOPE;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG METABOLISM; HUMAN; HUMAN CELL; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RNA SYNTHESIS;

ADENOSINE; CELL SURVIVAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; CYTIDINE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; LEUKEMIA; METHANOL; RIBONUCLEOTIDES; RNA, NEOPLASM; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0026581982     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(92)90218-8     Document Type: Article

References (29)

1. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells
2. Antitumor activity and biochemical effects of Cyclopentenyl cytosine in mice
3. Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties
4. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase
5. Cellular pharmacology of Cyclopentenyl cytosine in Molt-4 lymphoblasts
6. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and cytosine arabinoside by Cyclopentenyl cytosine
7. Mechanism of action of Cyclopentenyl cytosine and biochemical modulation of cytosine arabinoside
8. Biochemical effects and metabolism of Cyclopentenyl cytosine in human colon carcinoma cells
9. Heterogeneity of malignant cells from a human colonie carcinoma
10. Characteristics of cell lines established from human colorectal carcinoma
11. Augmentation of 5-ftuorouracil cytotoxicity in human colon cancer cells by dipyridamole
12. Purification and properties of cytidine deaminase from normal and leukemic granulocytes
13. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs
14. Quantitation of 1-β-d-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-β-d-arabinofuranosylcytosine therapy
15. Simultaneous determination of 1-beta-d-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography
16. A rapid quantitative determination of deoxyribonucleoside triphosphate based on the enzymatic synthesis of DNA
17. Methods for the determination of deoxyribonucleotide triphosphate concentrations
18. Pharmacokinetics and metabolism of Cyclopentenyl cytosine in primates: Evidence for deammation as the primary route of elimination
19. Correlation of cytotoxicity with incorporation of ara-C into DNA
20. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction
22. Alteration of fluorouracil metabolism in human colon cancer cells with a selective increase in fluorodeoxyuridine monophosphate levels
23. Cyclopentenyl cytosine: Interspecies predictions based on rodent plasma and urine kinetics
24. Kinetics of N-(phosphonacetyl)-l-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells
25. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture
26. Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA
27. Precursor-dependent differences in the incorporation of fluorouracil in RNA
28. Fluoropyrimidine-mediated changes in small nuclear RNA
29. RNA as a target for antimetabolites